Novo Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products OAD . Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management NovoSeven R RT , growth hormone therapy, hormone replacement therapy and other products.
Quote | Novo Nordisk A/S (NYSE:NVO)
Last: | $126.87 |
---|---|
Change Percent: | -0.33% |
Open: | $127.51 |
Close: | $127.29 |
High: | $128.43 |
Low: | $126.78 |
Volume: | 2,666,695 |
Last Trade Date Time: | 05/08/2024 03:00:00 am |
News | Novo Nordisk A/S (NYSE:NVO)
2024-05-07 13:24:47 ET More on Fresenius Medical Care Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript Fresenius Medical Care AG 2023 Q4 - Results - Earnings Call P...
2024-05-04 15:30:00 ET Read the full article on Seeking Alpha For further details see: Pharma R&D productivity seen improving for the first time in years - Deloitte
Message Board Posts | Novo Nordisk A/S (NYSE:NVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $NVO News Article - Got $5,000? 2 Unstoppable Stocks to Buy and Hold Forever | whytestocks | investorshangout | 04/20/2023 12:45:49 PM |
whytestocks: $NVO News Article - Why Wegovy and Ozempic Could Be Cash Cows for Novo Nordisk | whytestocks | investorshangout | 04/12/2023 3:45:45 PM |
whytestocks: $NVO News Article - Which Healthcare Company Will Be the First to Get to a $1 Trillion | whytestocks | investorshangout | 04/12/2023 3:40:47 PM |
whytestocks: $NVO News Article - 2 Stocks That Could Be Red-Hot Buys in 2023 | whytestocks | investorshangout | 12/14/2022 7:50:48 PM |
whytestocks: $NVO News Article - Novo Nordisk (NVO) Q1 2022 Earnings Call Transcript | whytestocks | investorshangout | 04/29/2022 4:45:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk A/S Company Name:
NVO Stock Symbol:
NYSE Market:
Tesla and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving his...
2024-05-03 07:00:00 ET Novo Nordisk 's (NYSE: NVO) success hinges on two key products: Ozempic and Wegovy. The former is a diabetes treatment, while the latter is its fast-growing weight-loss drug. Both are comparable and have been associated with helping people lose significant bod...
Online pharmacies and slimming clinics in Britain are reducing prices for Novo Nordisk A/S’s (NYSE:NVO) Wegovy and&n...